GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (OTCPK:RADLY) » Definitions » COGS-to-Revenue

RADLY (Raia Drogasil) COGS-to-Revenue : 0.71 (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Raia Drogasil COGS-to-Revenue?

Raia Drogasil's Cost of Goods Sold for the three months ended in Mar. 2025 was $1,245 Mil. Its Revenue for the three months ended in Mar. 2025 was $1,746 Mil.

Raia Drogasil's COGS to Revenue for the three months ended in Mar. 2025 was 0.71.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Raia Drogasil's Gross Margin % for the three months ended in Mar. 2025 was 28.69%.


Raia Drogasil COGS-to-Revenue Historical Data

The historical data trend for Raia Drogasil's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil COGS-to-Revenue Chart

Raia Drogasil Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.71 0.70 0.70 0.70 0.70

Raia Drogasil Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.70 0.70 0.70 0.71

Raia Drogasil COGS-to-Revenue Calculation

Raia Drogasil's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=4477.092 / 6370.178
=0.70

Raia Drogasil's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1244.811 / 1745.543
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raia Drogasil  (OTCPK:RADLY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Raia Drogasil's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 1244.811 / 1745.543
=28.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Raia Drogasil COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company is engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines. Its brands include Impulso, Amplimed, HealthBit, Stix, 4Bio, Drogasil, Raia and others.

Raia Drogasil Headlines